arc Buyse holds a ScD in biostatistics from the Harvard School of Public Health (Boston, MA). He worked at the EORTC in Brussels and at the Dana Farber Cancer Institute in Boston. He is the founder of the International Drug Development Institute (IDDI) and of CluePoints, two biostatistical service organizations based in the US and Europe. Marc’s research interests include clinical trial design, validation of biomarkers and surrogate endpoints, statistical methods in oncology, statistical detection of errors and meta-analysis
Oncology